Literature DB >> 22458495

Patient knowledge about prostate-specific antigen (PSA) and prostate cancer in Australia.

David Pan1, Philip McCahy.   

Abstract

OBJECTIVE: To assess whether men undergoing prostate biopsies for raised prostate-specific antigen (PSA) concentrations were adequately counselled before their first PSA test. PATIENTS AND METHODS: Men were given a PSA information sheet and interviewed immediately before undergoing transrectal ultrasonography (TRUS)/prostate biopsy. Information collected included whether they had been informed of the test, whether they were aware of TRUS/biopsy and whether possible treatments for prostate cancer had been discussed. They were asked whether the information sheet would have changed their opinion on testing.
RESULTS: 50 men were interviewed and 48 had their first test arranged by their general practitioner. 12.5% of men were adequately counselled using recently defined criteria. 4 (8.3%) men would not have had a PSA test if they had received adequate prior information
CONCLUSIONS: Counselling before serum PSA testing remains inadequate. Patient information sheets may help the discussions and should be made more widely available.
© 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458495     DOI: 10.1111/j.1464-410X.2012.11048.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  2 in total

1.  Experiences of Uncertainty in Men With an Elevated PSA.

Authors:  Caitlin Biddle; Alicia Brasel; Willie Underwood; Heather Orom
Journal:  Am J Mens Health       Date:  2016-06-23

2.  Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.

Authors:  Rae Thomas; Paul Glasziou; Lucie Rychetnik; Geraldine Mackenzie; Robert Gardiner; Jenny Doust
Journal:  BMJ Open       Date:  2014-12-24       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.